Combining the synergies that exist between Pharmaster, TRPO and SVS will bring greater competitive value to large scale projects in the pharmaceutical industry.

The companies Pharmaster, TPRO Engenharia do Brasil and SVS Consulting Services have reached an agreement to create the United Pharmaceutical Technologies Consortium in order to provide highly competitive solutions for projects associated with the Life Sciences industries.

The combination of synergies and the complementary attributes of the three companies will enable the rapid development of sound technical solutions for the design, installation, commissioning and evaluation of systems critical to the pharmaceuticals, bio-technologies, cosmetics and veterinary industries, directed in particular towards larger and more complex projects.

The companies making up the consortium have a substantial penetration and presence in the Brazilian market. Complementary resources and know-how will bring particular benefits to medium and large volume projects, providing competitive advantages derived from the combination of synergies of the three companies. The United Pharmaceutical Technologies Consortium can provide the design, installation, evaluation and commissioning of not only a specific unit, but also a complete plant, including engineering, installation, evaluation and certification and management services.

This partnership agreement does not signify the loss of identity of any of the companies making up the consortium. Each one will maintain its independence and its own commitments. In fact, each one of the companies of the consortium will continue to operate autonomously and independently in the market, supporting projects of small and medium sized companies, just as they have been doing up to now.